期刊文献+

单克隆抗体技术在阿尔茨海默病中的应用 被引量:1

下载PDF
导出
摘要 单克隆抗体具有无限增殖性和高特异性的优点,因此有很好的临床利用价值。最近国内外开发出了一系列针对治疗阿尔茨海默病的单克隆抗体,并进行了大量的实验研究,结果显示其对于阿尔茨海默病有很好的治疗作用,目前研究的主要是鼠源性单抗,包括抗B淀粉样多肽(Ap)单克隆抗体和抗微管相关蛋白Tau单克隆抗体两大类,人源化单抗也在不断研究之中。本文就此进行综述。
作者 赵正卿 万琪
出处 《国外医学(老年医学分册)》 2006年第6期241-244,共4页 Foreign Medical Sciences(Geriatrics)
  • 相关文献

参考文献22

  • 1Selkoe DJ.Alzheimer's disease:A central role for amyloid.Neuropatbol Exp Neurol,1994; 52:438 ~447
  • 2K(o)hler JF,Milstein C.Continuous cultures of fused cells secreting antibody of predefined specificity.Neture,1975;256 (5517):495 ~497
  • 3Yan SD,Chen X,Fu J et al.RAGE and amyloid-B peptide neurotoxicity in lzheimer's disease.Nature,1996;382:685~691
  • 4Marx J.Boring on β-amyloid role in Alzheimer's disease.Science,1992:255:688~689
  • 5Schenk D,Seubert P,Ciccarelli RB.Immunization with A β attenuates Alzheimer's disease -like pathology in the PDAPP mouse.Nature,1999; 400:173 ~ 177
  • 6Bayer AJ,Bullock R,Jones RW et al.Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792)in patients with AD.Neurology,2005; 64:94 ~ 101
  • 7Hardy J,Selkoe DJ.The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics.Science,2002; 297:353 ~ 356
  • 8DeMattos RB,Bales KR,Cummins DJ.Peripheral anti -Aβ antibody alters CNS and plasma Aβ Clearance and decreases brain AβBurden in a mouse model of Alzheimer's disease.PNAS,2001; 98:8850~8855
  • 9Bard F,Cannon C,Barbour R.Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.Nat Med,2000; 6:916~919
  • 10Manea M,Mezo G,Hudecz,F,Przybylsik M.Polypeptide conjugates comprising a beta-amyloid plaque-specific epitope as new vaccine structures againse Alzheimer's disease.Bioopolymers,2004; 76 (6):503~511

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部